GE Healthcare releases next-generation sequencing assay for use in clinical trials

[News]

GE Healthcare announced today that Clarient Diagnostic Services, Inc., a GE Healthcare company, will begin offering a next-generation sequencing assay focused on solid tumor targets for use in clinical trials.

More... (http://www.news-medical.net/news/20130408/GE-Healthcare-releases-next-generation-sequencing-assay-for-use-in-clinical-trials.aspx)